GAD2 and type 1 diabetes mellitus: Conversely, serum autoantibodies of uncomplicated T1D patients showed significant binding with ROS-GAD65 (OD; 0.58 ± 0.04, p < .0001) as compared to N-GAD65 (OD; 0.35 ± 0.03).